About T&L
T&L is a company based in Yongin (South Korea) founded in 1998. The company has 220 employees. T&L offers products and services including Medical Products and Chemical Products. T&L operates in a competitive market with competitors including Adhezion Biomedical, HyperBranch Medical, BRIJ Medical, BORAYER and Inno Therapy, among others.
- Annual Revenue$113.67 M (USD)-6.14as on Dec 31, 2025
- Net Profit$26.36 M (USD)-17.96as on Dec 31, 2025
- EBITDA$35.32 M (USD)-16.17as on Dec 31, 2025
- Employee Count220
Associated legal entities of T&L
T&L operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | – | – | – | View details |
Products & Services of T&L
T&L offers a comprehensive portfolio of products and services, including Medical Products and Chemical Products.
Products for safe wound and fracture treatment applications.
Additives for paint, textiles, and industrial processes.
IPO & Listings of T&L
T&L is a publicly listed company on the KRX with ticker symbol 340570 in South Korea, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date20 Nov 2020
- Listed onKRX: 340570
- Listed entityT&L Co. Ltd.
- Exchange sectorProcess industries
- ISINKR7340570001
- Share price27,400.00 KRW (-4.03% on the day) · 2026-10-08
- Market capitalisation438,787,204,361.00 KRW
- Price to earnings8.7
- EPS (diluted, trailing year)3,162.32 KRW
- Dividend yield2.74%
- Volume (last session)46,879
Financials of T&L
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 164.16B KRW | 38.07B KRW | 51.01B KRW |
| 2024 | 174.89B KRW | 46.41B KRW | 60.86B KRW |
| 2023 | 115.46B KRW | 27.44B KRW | 33.64B KRW |
| 2022 | 81.58B KRW | 21.12B KRW | 26.41B KRW |
| 2021 | 71.90B KRW | 19.58B KRW | 24.02B KRW |
Balance sheet, profit and loss, cash flow and ratios of , are on its company page.
Detailed financial statements for T&L
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of T&L
T&L operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adhezion Biomedical, HyperBranch Medical, BRIJ Medical, BORAYER and Inno Therapy, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| adhezion.com | 2001 | Wyomissing, United States | $10.14M | 39 | Developer of cyanoacrylate based surgical, wound management, and infection prevention products | |
| hyperbranch.com | 2003 | Durham, United States | $18.69M | – | Biosurgical devices are developed using proprietary polymers and hydrogels. | |
| brijmedical.com | 2016 | Marietta, United States | $6.78M | – | Medical devices for post-surgical and trauma incision care are provided. | |
| borayer.com | 2020 | Nanchang, China | – | – | Biomaterials for surgery and wound repair are developed. | |
| innotherapy.com | 2010 | Seoul, South Korea | $2.77M | – | Hemostatic polymers are produced for surgical and wound care applications. | |
| musselpolymers.com | 2019 | Bethlehem, United States | $500,000 | – | Adhesive solutions are manufactured for diverse materials and applications. | |
| adhesys-medical.com | 2013 | Aachen, Germany | – | 4 | Manufacturer of bio-degradable polyurethane-based surgical sealants | |
| cuantum.me | 2015 | – | $1.74M | – | Developer of cyanoacrylate adhesives for wound care | |
| suturegard.com | 2015 | Portland, United States | $580,000 | – | Wound closure devices for skin are manufactured by Suturegard. | |
| finessemedical.com | 2004 | Dublin, Ireland | – | – | Wound and skin care products are developed, manufactured, and marketed. |
Detailed competitors of TL
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of T&L
The website of T&L (tnl.co.kr) receives about 6K visits a month.
- Monthly visits6K
▲ 12.8% vs previous month
Websites whose visitors overlap most with T&L. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
itooza.com | itooza.com | 100% | – | #291,784 | – |
| dailyinvest.kr | 96% | – | #675,680 | View details | |
smarttoday.co.kr | smarttoday.co.kr | 92% | – | #183,106 | – |
whoniz.com | whoniz.com | 26% | – | #6,499,284 | – |
riche-bio.com | riche-bio.com | 25% | – | #4,578,858 | – |
Latest news on T&L
Complete news archive for TL
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to T&L
10 companies that operate in the same segment as T&L (Wound Care), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Fish-skin acellular dermal matrix technology is provided for wound treatments. | 2007 | Isafjordur, Iceland | USD 93.11 M | – | 150 | |
Developer of advanced haemostat and wound care dressing products | 2008 | Ahmedabad, Gujarat, India | USD 42.71 M | USD 2.88 M | 70 | |
Oxygen-based wound therapy devices are developed for healing non-healing wounds. | 2003 | Waterbeach, Cambridgeshire, United Kingdom | USD 68.39 M | – | – | |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | – | USD 418.63 M | 837 | |
Biological drugs for skin and mucosa wound treatment are developed. | 2016 | Uppsala, Uppsala County, Sweden | USD 4.02 M | USD 1.12 M | – | |
Developer of hemostatic products for wound care | 2010 | New York, New York, United States | USD 113.35 M | – | – | |
Regenerative therapies for wound care are developed and commercialized. | 1985 | Canton, Ohio, United States | USD 30 M | USD 564.17 M | 869 | |
Cold plasma solutions for wound treatment are developed. | 2013 | Eindhoven, Noord-brabant, Netherlands | USD 7.06 M | – | – | |
Point-of-care devices for wound bacterial assessment are provided. | 2013 | Toronto, Ontario, Canada | USD 43.2 M | – | 49 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about T&L
T&L was founded in 1998.
T&L is headquartered in Yongin, South Korea. It is registered at Yongin, Gyeonggi, South Korea.
T&L has 220 employees.
Annual revenue of T&L is $113.67M as on Dec 31, 2025.
TL Co. was founded in 1998 in South Korea. High-molecule technological products are developed for the orthopedic and wound care sectors. Orthopedic offerings include casts, flex materials, elasticast, splints, finger splints, ever fresh padding, and thunder braces. Wound care items encompass hydro-colloid dressings, Renofoam variants (non-adhesive and self-adhesive), hydrogel dressings, and perforated silicone foams. Operations center on polymer-based materials for these medical applications.
T&L's top competitors include Adhezion Biomedical, BRIJ Medical and Inno Therapy.
T&L offers Medical Products and Chemical Products.
Yes, T&L is publicly traded on KRX under the ticker symbol 340570.
T&L operates through ,.